IBDEI069 ; ; 12-JAN-2012
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JAN 12, 2012
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8232,0)
 ;;=V10.72^^62^465^53
 ;;^UTILITY(U,$J,358.3,8232,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8232,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,8232,1,5,0)
 ;;=5^Personal H/O Hodgkin'S Disease
 ;;^UTILITY(U,$J,358.3,8232,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,8233,0)
 ;;=V15.3^^62^465^54
 ;;^UTILITY(U,$J,358.3,8233,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8233,1,4,0)
 ;;=4^V15.3
 ;;^UTILITY(U,$J,358.3,8233,1,5,0)
 ;;=5^Personal H/O Irradiation
 ;;^UTILITY(U,$J,358.3,8233,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,8234,0)
 ;;=V10.61^^62^465^29
 ;;^UTILITY(U,$J,358.3,8234,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8234,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,8234,1,5,0)
 ;;=5^Hx Of Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,8234,2)
 ;;=Hx of Lymphoid Leukemia^295232
 ;;^UTILITY(U,$J,358.3,8235,0)
 ;;=V12.03^^62^465^30
 ;;^UTILITY(U,$J,358.3,8235,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8235,1,4,0)
 ;;=4^V12.03
 ;;^UTILITY(U,$J,358.3,8235,1,5,0)
 ;;=5^Hx Of Malaria
 ;;^UTILITY(U,$J,358.3,8235,2)
 ;;=Hx of Malaria^303395
 ;;^UTILITY(U,$J,358.3,8236,0)
 ;;=V10.82^^62^465^31
 ;;^UTILITY(U,$J,358.3,8236,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8236,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,8236,1,5,0)
 ;;=5^Hx Of Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,8236,2)
 ;;=Hx of Malignant Melanoma^295240
 ;;^UTILITY(U,$J,358.3,8237,0)
 ;;=V10.62^^62^465^33
 ;;^UTILITY(U,$J,358.3,8237,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8237,1,4,0)
 ;;=4^V10.62
 ;;^UTILITY(U,$J,358.3,8237,1,5,0)
 ;;=5^Hx Of Myeloid Leukemia
 ;;^UTILITY(U,$J,358.3,8237,2)
 ;;=Hx of Myeloid Leukemia^295233
 ;;^UTILITY(U,$J,358.3,8238,0)
 ;;=V10.63^^62^465^32
 ;;^UTILITY(U,$J,358.3,8238,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8238,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,8238,1,5,0)
 ;;=5^Hx Of Monocytic Leukemia
 ;;^UTILITY(U,$J,358.3,8238,2)
 ;;=Hx of Monocytic Leukemia^295234
 ;;^UTILITY(U,$J,358.3,8239,0)
 ;;=V11.2^^62^465^27
 ;;^UTILITY(U,$J,358.3,8239,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8239,1,4,0)
 ;;=4^V11.2
 ;;^UTILITY(U,$J,358.3,8239,1,5,0)
 ;;=5^Hx Of Dysthymia
 ;;^UTILITY(U,$J,358.3,8239,2)
 ;;=Hx of Dysthymia^295251
 ;;^UTILITY(U,$J,358.3,8240,0)
 ;;=V15.81^^62^465^43
 ;;^UTILITY(U,$J,358.3,8240,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8240,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,8240,1,5,0)
 ;;=5^Noncompliance With Medical Treatment
 ;;^UTILITY(U,$J,358.3,8240,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,8241,0)
 ;;=V10.43^^62^465^34
 ;;^UTILITY(U,$J,358.3,8241,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8241,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,8241,1,5,0)
 ;;=5^Hx Of Ovarian Ca
 ;;^UTILITY(U,$J,358.3,8241,2)
 ;;=Hx of Ovarian CA^295221
 ;;^UTILITY(U,$J,358.3,8242,0)
 ;;=V12.71^^62^465^35
 ;;^UTILITY(U,$J,358.3,8242,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8242,1,4,0)
 ;;=4^V12.71
 ;;^UTILITY(U,$J,358.3,8242,1,5,0)
 ;;=5^Hx Of Peptic Ulcer Disease
 ;;^UTILITY(U,$J,358.3,8242,2)
 ;;=^303400
 ;;^UTILITY(U,$J,358.3,8243,0)
 ;;=V10.46^^62^465^36
 ;;^UTILITY(U,$J,358.3,8243,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8243,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,8243,1,5,0)
 ;;=5^Hx Of Prostate Cancer
 ;;^UTILITY(U,$J,358.3,8243,2)
 ;;=Hx of Prostate Cancer^295224
 ;;^UTILITY(U,$J,358.3,8244,0)
 ;;=V11.0^^62^465^37
 ;;^UTILITY(U,$J,358.3,8244,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8244,1,4,0)
 ;;=4^V11.0
 ;;^UTILITY(U,$J,358.3,8244,1,5,0)
 ;;=5^Hx Of Schizophrenia
 ;;^UTILITY(U,$J,358.3,8244,2)
 ;;=Hx of Schizophrenia^295249
 ;;^UTILITY(U,$J,358.3,8245,0)
 ;;=V10.83^^62^465^38
 ;;^UTILITY(U,$J,358.3,8245,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8245,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,8245,1,5,0)
 ;;=5^Hx Of Skin Cancer (Non-Melanoma)
 ;;^UTILITY(U,$J,358.3,8245,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,8246,0)
 ;;=V15.1^^62^465^39
 ;;^UTILITY(U,$J,358.3,8246,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8246,1,4,0)
 ;;=4^V15.1
 ;;^UTILITY(U,$J,358.3,8246,1,5,0)
 ;;=5^Hx Of Surgery To Heart And Great Vessels
 ;;^UTILITY(U,$J,358.3,8246,2)
 ;;=^295283
 ;;^UTILITY(U,$J,358.3,8247,0)
 ;;=V15.82^^62^465^41
 ;;^UTILITY(U,$J,358.3,8247,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8247,1,4,0)
 ;;=4^V15.82
 ;;^UTILITY(U,$J,358.3,8247,1,5,0)
 ;;=5^Hx Of Tobacco Use (Not Current)
 ;;^UTILITY(U,$J,358.3,8247,2)
 ;;=Hx of Tobacco Use (not current)^303405
 ;;^UTILITY(U,$J,358.3,8248,0)
 ;;=V12.01^^62^465^40
 ;;^UTILITY(U,$J,358.3,8248,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8248,1,4,0)
 ;;=4^V12.01
 ;;^UTILITY(U,$J,358.3,8248,1,5,0)
 ;;=5^Hx Of Tb
 ;;^UTILITY(U,$J,358.3,8248,2)
 ;;=Hx of TB^303393
 ;;^UTILITY(U,$J,358.3,8249,0)
 ;;=V13.01^^62^465^28
 ;;^UTILITY(U,$J,358.3,8249,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8249,1,4,0)
 ;;=4^V13.01
 ;;^UTILITY(U,$J,358.3,8249,1,5,0)
 ;;=5^Hx Of Kidney Stones
 ;;^UTILITY(U,$J,358.3,8249,2)
 ;;=Hx of Kidney Stones^303403
 ;;^UTILITY(U,$J,358.3,8250,0)
 ;;=V12.51^^62^465^42
 ;;^UTILITY(U,$J,358.3,8250,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8250,1,4,0)
 ;;=4^V12.51
 ;;^UTILITY(U,$J,358.3,8250,1,5,0)
 ;;=5^Hx Of Venous Thrombosis And Embolism
 ;;^UTILITY(U,$J,358.3,8250,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,8251,0)
 ;;=V17.89^^62^465^1
 ;;^UTILITY(U,$J,358.3,8251,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8251,1,4,0)
 ;;=4^V17.89
 ;;^UTILITY(U,$J,358.3,8251,1,5,0)
 ;;=5^Fam Hx Musculosk Dis
 ;;^UTILITY(U,$J,358.3,8251,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,8252,0)
 ;;=V12.54^^62^465^26
 ;;^UTILITY(U,$J,358.3,8252,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8252,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,8252,1,5,0)
 ;;=5^HX of TIA
 ;;^UTILITY(U,$J,358.3,8252,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,8253,0)
 ;;=V12.54^^62^465^25
 ;;^UTILITY(U,$J,358.3,8253,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8253,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,8253,1,5,0)
 ;;=5^HX of Stroke w/o Residuals
 ;;^UTILITY(U,$J,358.3,8253,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,8254,0)
 ;;=V15.88^^62^465^23
 ;;^UTILITY(U,$J,358.3,8254,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8254,1,4,0)
 ;;=4^V15.88
 ;;^UTILITY(U,$J,358.3,8254,1,5,0)
 ;;=5^HX of Falls
 ;;^UTILITY(U,$J,358.3,8254,2)
 ;;=^332859
 ;;^UTILITY(U,$J,358.3,8255,0)
 ;;=V13.59^^62^465^24
 ;;^UTILITY(U,$J,358.3,8255,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8255,1,4,0)
 ;;=4^V13.59
 ;;^UTILITY(U,$J,358.3,8255,1,5,0)
 ;;=5^HX of Musculoskletl Dis NEC
 ;;^UTILITY(U,$J,358.3,8255,2)
 ;;=^295268
 ;;^UTILITY(U,$J,358.3,8256,0)
 ;;=V12.04^^62^465^55
 ;;^UTILITY(U,$J,358.3,8256,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8256,1,4,0)
 ;;=4^V12.04
 ;;^UTILITY(U,$J,358.3,8256,1,5,0)
 ;;=5^Personal H/O MRSA infection
 ;;^UTILITY(U,$J,358.3,8256,2)
 ;;=^336780
 ;;^UTILITY(U,$J,358.3,8257,0)
 ;;=V62.22^^62^465^58
 ;;^UTILITY(U,$J,358.3,8257,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8257,1,4,0)
 ;;=4^V62.22
 ;;^UTILITY(U,$J,358.3,8257,1,5,0)
 ;;=5^Personal H/O Retrn Military Deploy
 ;;^UTILITY(U,$J,358.3,8257,2)
 ;;=^336807
 ;;^UTILITY(U,$J,358.3,8258,0)
 ;;=V13.51^^62^465^56
 ;;^UTILITY(U,$J,358.3,8258,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8258,1,4,0)
 ;;=4^V13.51
 ;;^UTILITY(U,$J,358.3,8258,1,5,0)
 ;;=5^Personal H/O Pathological FX
 ;;^UTILITY(U,$J,358.3,8258,2)
 ;;=^336781
 ;;^UTILITY(U,$J,358.3,8259,0)
 ;;=V15.51^^62^465^60
 ;;^UTILITY(U,$J,358.3,8259,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8259,1,4,0)
 ;;=4^V15.51
 ;;^UTILITY(U,$J,358.3,8259,1,5,0)
 ;;=5^Personal H/O Traumatic FX
 ;;^UTILITY(U,$J,358.3,8259,2)
 ;;=^336786
 ;;^UTILITY(U,$J,358.3,8260,0)
 ;;=V15.52^^62^465^59
 ;;^UTILITY(U,$J,358.3,8260,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8260,1,4,0)
 ;;=4^V15.52
 ;;^UTILITY(U,$J,358.3,8260,1,5,0)
 ;;=5^Personal H/O Traumatic Brain Injury
 ;;^UTILITY(U,$J,358.3,8260,2)
 ;;=^338495
 ;;^UTILITY(U,$J,358.3,8261,0)
 ;;=V70.0^^62^466^1
 ;;^UTILITY(U,$J,358.3,8261,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8261,1,4,0)
 ;;=4^V70.0
 ;;^UTILITY(U,$J,358.3,8261,1,5,0)
 ;;=5^Routine Med Exam
 ;;^UTILITY(U,$J,358.3,8261,2)
 ;;=^295590
 ;;^UTILITY(U,$J,358.3,8262,0)
 ;;=V77.91^^62^466^2
 ;;^UTILITY(U,$J,358.3,8262,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8262,1,4,0)
 ;;=4^V77.91
 ;;^UTILITY(U,$J,358.3,8262,1,5,0)
 ;;=5^Screen For High Cholesterol
 ;;^UTILITY(U,$J,358.3,8262,2)
 ;;=Screen for High Cholesterol^322093
 ;;^UTILITY(U,$J,358.3,8263,0)
 ;;=V76.44^^62^466^3
 ;;^UTILITY(U,$J,358.3,8263,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8263,1,4,0)
 ;;=4^V76.44
 ;;^UTILITY(U,$J,358.3,8263,1,5,0)
 ;;=5^Screen For Prostate Ca
 ;;^UTILITY(U,$J,358.3,8263,2)
 ;;=Screen for Prostate CA^321548
 ;;^UTILITY(U,$J,358.3,8264,0)
 ;;=V74.5^^62^466^5
 ;;^UTILITY(U,$J,358.3,8264,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8264,1,4,0)
 ;;=4^V74.5
 ;;^UTILITY(U,$J,358.3,8264,1,5,0)
 ;;=5^Screening For Std'S
 ;;^UTILITY(U,$J,358.3,8264,2)
 ;;=Screening for STD's^295637
 ;;^UTILITY(U,$J,358.3,8265,0)
 ;;=V73.89^^62^466^4
 ;;^UTILITY(U,$J,358.3,8265,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8265,1,4,0)
 ;;=4^V73.89
 ;;^UTILITY(U,$J,358.3,8265,1,5,0)
 ;;=5^Screening For Hiv
 ;;^UTILITY(U,$J,358.3,8265,2)
 ;;=^295833
 ;;^UTILITY(U,$J,358.3,8266,0)
 ;;=919.1^^62^467^1
 ;;^UTILITY(U,$J,358.3,8266,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8266,1,4,0)
 ;;=4^919.1
 ;;^UTILITY(U,$J,358.3,8266,1,5,0)
 ;;=5^Abrasion, Infected
 ;;^UTILITY(U,$J,358.3,8266,2)
 ;;=^275358
 ;;^UTILITY(U,$J,358.3,8267,0)
 ;;=919.0^^62^467^2
 ;;^UTILITY(U,$J,358.3,8267,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8267,1,4,0)
 ;;=4^919.0
 ;;^UTILITY(U,$J,358.3,8267,1,5,0)
 ;;=5^Abrasion, Not Infected
 ;;^UTILITY(U,$J,358.3,8267,2)
 ;;=^1305
 ;;^UTILITY(U,$J,358.3,8268,0)
 ;;=924.9^^62^467^3
 ;;^UTILITY(U,$J,358.3,8268,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8268,1,4,0)
 ;;=4^924.9
 ;;^UTILITY(U,$J,358.3,8268,1,5,0)
 ;;=5^Bite, Human, Contusion
